Reviva Pharmaceuticals Holdings, Inc. (RVPH) Tops Q1 EPS by 8c

Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) reported Q1 EPS of ($0.13), $0.08 better than the analyst estimate of ($0.21).

For earnings history and earnings-related data on Reviva Pharmaceuticals Holdings, Inc. (RVPH) click here.

You May Also Be Interested In

• FDA Committee Recommends To Widen Access To Bpc-157 Peptide
• Wolfe upgrades AT&T to Outperform as improving fundamentals outweigh Starlink risk
• Rollins shares plunge premarket after Q2 miss triggers downgrades